Medication adherence and tolerability of Alzheimer’s disease medications: study protocol for a randomized controlled trial

BACKGROUND: The class of acetylcholinesterase inhibitors (ChEI), including donepezil, rivastigmine, and galantamine, have similar efficacy profiles in patients with mild to moderate Alzheimer’s disease (AD). However, few studies have evaluated adherence to these agents. We sought to prospectively ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, Noll L, Dexter, Paul, Perkins, Anthony J, Gao, Sujuan, Li, Lang, Skaar, Todd C, Frame, Amie, Hendrie, Hugh C, Callahan, Chris M, Boustani, Malaz A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764973/
https://www.ncbi.nlm.nih.gov/pubmed/23782591
http://dx.doi.org/10.1186/1745-6215-14-125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764973/
https://www.ncbi.nlm.nih.gov/pubmed/23782591
http://dx.doi.org/10.1186/1745-6215-14-125

Ejemplares similares